Hsa_circ_0001445 works as a cancer suppressor via miR-576-5p/SFRP1 axis regulation in ovarian cancer.

Yuhong WuJinhua ZhouYan LiXiu ShiFangrong ShenMingwei ChenYouguo Chen Juan Wang

Published in: Cancer medicine (2022)

hcR1445 acts an antioncogene by targeting the miR-576-5p/SFRP1 axis and blocking OC progression and development. Thus, hcR1445 may be employed as an indicator or a possible therapeutic target in OC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
papillary thyroid
prognostic factors
patient reported outcomes
young adults
lymph node metastasis